John Moliterni

Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), A Potent and Selective Cyclin-Dependent Kinase Inhibitor with Significant in Vivo Antitumor Activity

Xin‐Jie Chu, Wanda DePinto, David Bartkovitz et al. · Journal of Medicinal Chemistry · 2006 · 116 citations · Full text

Drug Target, Pharmacotherapy, Cell Cycle +17

Potent and Selective Non-Peptidic Inhibitors of Endothelin-Converting Enzyme-1 with Sustained Duration of Action

Stéphane De Lombaert, Louis Blanchard, Lisa B. Stamford et al. · Journal of Medicinal Chemistry · 2000 · 100 citations · Full text

Cgs 35066, Selective Non-peptidic Inhibitors, Pharmacotherapy +17

Design and Synthesis of Potent, Selective Inhibitors of Endothelin-Converting Enzyme

Eli M. Wallace, John Moliterni, Michael A. Moskal et al. · Journal of Medicinal Chemistry · 1998 · 52 citations · Full text

Optimization of Benzodiazepinones as Selective Inhibitors of the X-Linked Inhibitor of Apoptosis Protein (XIAP) Second Baculovirus IAP Repeat (BIR2) Domain

Robert F. Kester, Andrew F. Donnell, Yan Lou et al. · Journal of Medicinal Chemistry · 2013 · 38 citations · Full text

X-linked Inhibitor, Xiap Bir3, Drug Target +14

Benzazepinones and Benzoxazepinones as Antagonists of Inhibitor of Apoptosis Proteins (IAPs) Selective for the Second Baculovirus IAP Repeat (BIR2) Domain

Andrew F. Donnell, Christophe Michoud, Kenneth C. Rupert et al. · Journal of Medicinal Chemistry · 2013 · 28 citations · Full text

Antiapoptotic Function, Pan-iap Inhibitors, Medicinal Chemistry +15